Analysts Point To Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Growth In The Future

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

Stocks Info

As a NASDAQ listed company, VNDA falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Vanda Pharmaceuticals Inc is $282.83M. A total of 0.61 million shares were traded on the day, compared to an average of 681.87K shares.

In the most recent transaction, Polymeropoulos Mihael Hristos bought 10,000 shares of VNDA for 5.01 per share on Mar 06 ’25. After the transaction, the President and CEO now owns 2,295,731 company shares. In a previous transaction on Mar 05 ’25, Polymeropoulos Mihael Hristos bought 10,000 shares at 5.02 per share. VNDA shares that President and CEO owns now total 2,285,731.

Among the insiders who bought shares, Polymeropoulos Mihael Hristos acquired of 10,000 shares on Mar 03 ’25 at a per-share price of $4.71. This resulted in the President and CEO holding 2,275,731 shares of VNDA after the transaction. In another insider transaction, Polymeropoulos Mihael Hristos bought 10,000 shares at $4.76 per share on Feb 28 ’25. Company shares held by the President and CEO now total 2,361,730.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, VNDA has a high of $6.75 and a low of $3.71.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. VNDA’s latest balance sheet shows that the firm has $432.81M in Cash & Short Term Investments as of fiscal 2021. There were $12.37M in debt and $74.42M in liabilities at the time. Its Book Value Per Share was $9.24, while its Total Shareholder’s Equity was $504.93M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VNDA is Buy with a score of 4.33.

Most Popular

Related Posts